北京时间5月14-17日，欧洲介入心脏病学大会（EuroPCR）将于法国巴黎隆重举行。作为世界领先的介入心血管医学课程，EuroPCR旨在通过分享心血管介入医学最新的知识、经验和实践来满足每一位患者的需求。在今年为期四天的会议上，全球介入心脏病学医师将共同聚焦3项将改变临床实践的主要最新临床研究结果。此外，会议还设置了9场涵盖了热线研究、最新临床研究的精彩会议，包括45项Hotline，15项随机临床研究以及6项最新临床研究。现在就让我们先睹为快，看一看本次EuroPCR为我们带来了哪些重磅研究。
Hotline：advances in coronary physiology
北京时间：05-14 17:45~19:15
Influence of pathophysiological patterns of CAD on the safety and efficacy of PCI
CAD病理生理学模式对PCI安全性及有效性的影响Prognostic value of MRR in STEMI: a pooled analysis of individual patient data
微血管阻力储备（MRR）在STEMI患者中的预后价值：个体患者数据的汇总分析QFR for the revascularization of non-culprit lesions of older patients with myocardial infarction
QFR指导老年心肌梗死患者非罪犯病变血运重建Angiography-based radial wall strain in predicting non-culprit vessel failure
基于血管造影术的径向壁应变预测非罪魁祸首血管衰竭Combining angiography and ad-hoc intracoronary testing in patients with chronic coronary syndromes
在慢性冠脉综合征患者中行造影结合专门冠脉内检测FFRangio-based PCI were associated with better 1-year clinical outcomes in an international registry
在一项国际注册研究中，基于FFRangio的PCI与更好的1年临床结局相关Diagnostic performance of fully automatic computational FFR in the CAREER study
CAREER研究中全自动计算FFR的诊断性能Diagnostic accuracy of fully automatic Murray law-based quantitative flow ratio
全自动mQFR的诊断精确性
Late-breaking trials: TAVI head-to-head
北京时间：05-14 17:45~19:15
Small aortic annuli patients treated with TAVI: outcomes in women in the SMART trial
TAVI治疗小瓣环患者：SMART研究中的女性结局Percutaneus versus surgical treatment for patients with aortic stenosis and coronary disease
主动脉瓣狭窄合并冠脉疾病的患者外科手术 vs. 经皮介入Impact of valve type and anaesthesia strategy for TAVI – 5-year results of the SOLVE-TAVI trial
瓣膜类型和麻醉策略对TAVI的影响——SOLVE-TAVI研究5年结果Long-term multiple comparison of transcatheter aortic valves – insights from the OBSERVANT II study
经导管主动脉瓣疗法的长期多重比较——来自OBSERVANT Ⅱ研究的见解Comparison of self-expanding versus balloon-expandable transcatheter aortic valves: 1-year outcomes
对比球扩瓣膜和自膨瓣——1年结果Balloon-expandable versus self-expanding transcatheter valves in raphe-type bicuspid aortic stenosis
raphe-type型二叶式主动脉瓣狭窄中球扩瓣 vs. 自膨瓣
Hotline: new coronary devices (DES, BRS, DCB)
北京时间：05-14 21:15~22:45
A randomised trial of iron bioresorbable scaffold compared with XIENCE in coronary artery disease
一项在冠状动脉疾病中对比金属生物可降解支架和XIENCE支架的随机试验Site-specific antithrombotic therapy: DESyne BDS Plus study 12-month outcomes
局部特定抗血栓治疗：DESyne BDS Plus研究12个月结果Two-year clinical outcomes of the BIOADAPTOR RCT study
BIOADAPTOR RCT研究两年临床结果Results of the magnesium BRS in complex lesions: data from the IT-Masters registry
镁金属BRS在复杂病变中的结果：IT-Masters注册研究数据Randomised trial of biolimus vs paclitaxel coated balloons for coronary in-stent restenosis
优美莫司涂层球囊与紫杉醇涂层球囊在冠脉支架内再狭窄中的随机试验Sirolimus vs paclitaxel DCB. A logistic regression analysis of EASTBOURNE and PEARL multicentre study
西罗莫司DCB vs. 紫杉醇DCB，一项EASTBOURNE和PEARL多中心研究的logistic回归分析Randomised comparison of Abluminus DES+ sirolimus-eluting stents versus everolimus-eluting stents in coronary artery disease patients with diabetes mellitus global: the ABILITY diabetes global study
在冠状动脉疾病合并糖尿病患者中对比Abluminus DES+西罗莫司洗脱支架和伊维莫司洗脱支架的随机研究：ABILITY diabetes global研究Patient and procedure characteristics for 1000 Selution SLRTM sirolimus-eluting balloon procedures
1000例Selcn SLRTM西罗莫司涂层球囊手术的患者和手术特点
Major Late-Breaking Trials from EuroPCR 2024
北京时间：05-15 14:30~16:00
One-month DAPT followed by 5-month Ticagrelor monotherapy in acute coronary syndromes with DCB
DCB治疗ACS患者一个月DAPT后5个月替格瑞洛单药治疗First TAVI vs. SAVR randomised trial in younger low-risk patients with severe tricuspid or bicuspid aortic valve stenosis - results from NOTION-2
针对三叶瓣或二叶瓣主动脉瓣狭窄的年轻低风险患者的首个TAVI对比SAVR的随机试验——来自NOTION-2的结果Early outcomes of a randomised non-inferiority trial comparing TAVI devices: the LANDMARK trial
一项对比TAVI器械的随机非劣效性试验的早期结果：LANDMARK试验
Randomised trials: substudies and extended follow-up - A quick update
北京时间：05-15 14:30~16:00
Keep bIfurcation Single stenting Simple
保持分叉病变单支架的简单性ORBITA2-Symptoms: the symptom-stratified analysis of ORBITA-2
ORBITA2-症状：ORBITA-2的症状分层分析Does completeness of revascularisation affect clinical outcomes? Insights from REVIVED-BCIS2
完全血运重建是否会影响临床结局？来自REVIVED-BCIS2的见解Is coronary artery bypass surgery cost-effective compared with contemporary PCI
当代PCI与冠脉搭桥术的成本-效益Hybrid coronary revascularisation–10-year clinical outcomes of the prospective randomised study.
冠脉血运重建杂交手术10年临床结果前瞻性随机研究Long-term outcomes after immediate versus staged complete revascularisation in STEMI or NSTE-ACS
在SETMI或NSTE-ACS患者中即刻或分期完全血运重建的长期结果Improved DES for left main PCI in an all-comers population: 5-year results of the IDEAL-LM Trial
全人群中改良DES行左主干PCI：IDEAL-LM试验的5年结果
TAVI hotline: long-term registry data
北京时间：05-15 16:30~18:00
Surgical versus transcatheter approach in combined coronary and aortic valve disease
在合并冠脉疾病与主动脉瓣疾病患者中外科手术 vs. 经导管入路Long-term outcomes of transcatheter aortic valve vs. surgical aortic valve replacement
经导管主动脉瓣置换 vs. 外科主动脉瓣置换的长期结果A prospective multicentre registry of a short-frame supra-annular transcatheter aortic valve
一项经导管主动脉低瓣架环上瓣的前瞻性多中心注册研究Initial experience of a novel intra-annular self-expanding transcatheter aortic valve in Japan.
日本新型经导管环中瓣自膨瓣的早期经验Redefining small aortic annulus in patients receiving a self-expanding transcatheter aortic valve
在接受自膨瓣的患者中重新定义小瓣环TAVR with a self-expandable bioprothesis: 12-year clinical and durability data
使用自膨胀假体的TAVR：12年临床和耐久性数据Long term clinical outcomes of the MyVal valve in patients with severe aortic stenosis
重度主动脉瓣狭窄患者使用MyVal瓣膜治疗的长期随访结果
TAVI Hotline: new devices, new approaches
北京时间：05-15 20:45~22:15
First report of an IDE pivotal study of a dedicated splitting device during TAVR
TAVR术中瓣叶切割装置首个IDE关键研究报告Upper extremity versus lower extremity for accessory access sites during TAVI
TAVI术中辅助入路位点的上肢和下肢选择First in man of the Vivasure PerQseal ELITE System for large hole closure: ELITE study
PerQseal ELITE系统在大孔闭合中的首次人体试验：ELITE studyDurAVR biomimetic transcatheter heart valve: early feasibility study update
仿生经导管心脏瓣膜DurAVR：早期可行性研究更新One-year efficacy and safety of the dry-pericardium aortic valve: A first-in-human feasibility study
干性心包主动脉瓣的一年安全性及有效性：首次人体可行性研究Using temporary permanent pacemaker as a one-month bridge after TAVI
TAVR术后一个月使用永久起搏器桥接治疗Clinical evaluation of the Hydra self-expanding THV: 30 days results from the GENESIS-II study
Hydra自膨胀瓣膜的临床评估：GENESIS-Ⅱ研究30天结果
First-in-man and out-of-the-box innovations hotline
北京时间：05-15 20:45~22:15
NeuroOCT (nOCT): turn on the light inside the skull
神经OCT（nOCT）：打开颅骨内的灯BackBeat: Atrio-Ventricular Interval Modulation (AVIM) for blood pressure control
BackBeat：房室间期调节（AVIM）疗法控制高血压First-in-Man safety and efficacy of renal stimulation with direct wire pacing during denervation procedure
肾去神经术中直接导丝起搏行肾脏刺激安全性及有效性的首次人体试验Results of the REDUCED 1 study assessing the TIVUS system in renal denervation
REDUCED 1研究评估TIVUS系统在肾去神经术中的结果Radial approach renal denervation: first-in-man study with the 4F TIVUS system
桡动脉入路RDN：使用4F的TIVUS系统的首次人体研究Renal Denervation as a day case procedure
RDN作为日间手术Multicenter registry on robotically assisted percutaneous coronary interventions - TESLA registry
机器人辅助的多中心注册研究——TESLA注册研究Robotic Tele-Surgery Stenting
机器人远程支架植入术Advances in Holographic Imaging for Procedural Planning and Guidance (Realview Imaging)
用于手术计划和指导的全息影像进展（实时成像）
First results of randomised trials on advanced plaque modification techniques and intracoronary imaging
北京时间：05-16 16:30~18:00
Does OCT optimise results of stenting on the left main: a randomised, controlled, multicentre trial
OCT是否能优化左主干支架植入结果：一项随机、对照、多中心试验Primary outcome of randomised controlled trial of the safety and effectiveness for OCT or IVUS-guide
OCT或IVUS指导的安全性和有效性，随机对照试验的主要结果OCT vs. angiography for guidance of calcified lesions PCI: the CALIPSO tria
OCT vs. 造影指导钙化病变PCI：CALIPSO试验Debulking with rotational atherectomy versus balloon angioplasty in patients with in-stent restenosis
支架内再狭窄患者使用冠脉内旋磨和球囊血管成形术行减容治疗的对比The laser atherectomy for STEMI, PCI analysis with scintigraphy study
激光消融术在STEMI患者中的作用，使用闪烁扫描分析PCI结果的研究Balloon angioplasty versus shockwave intravascular lithotripsy
球囊成形术 vs. SHOCKWAVE血管内碎石术Rotational atherectomy, lithotripsy or laser for calcified coronary stenosis
旋磨术、血管内碎石术、激光消融术治疗冠脉钙化狭窄
Mitral and tricuspid hotline
北京时间：05-16 20:45~22:15
Transcatheter mitral repair in patients with moderate mitral regurgitation: one-year outcomes from the MiCLASP study
经导管二尖瓣修复术在二尖瓣中等程度反流患者中的作用：MiCLASP研究一年结果Impact of intra-procedural residual mitral regurgitation and gradient following TEER for primary mitral regurgitation
TEER术中残余二尖瓣反流和跨瓣压差对原发性二尖瓣反流的影响Report on the AltaValve early feasibility study
AltaValve早期可行性研究报告One-year outcomes of transcatheter edge-to-edge repair for primary tricuspid regurgitation
经导管缘对缘修复原发性三尖瓣反流的一年结果Impact of residual tricuspid regurgitation after transcatheter tricuspid valve repair on survival
经导管三尖瓣修复术后残余三尖瓣反流对生存率的影响Transcatheter tricuspid valve implantation using the LuxValvePlus system: compassionate use outcomes
使用LuxValvePlus系统行经导管三尖瓣置换：同情使用结果Multivalvular disease in TAVR-patients: Multicentre study on impact of staged valvular interventions
TAVR患者中多瓣膜病变：分期瓣膜干预影响的多中心研究
《心关注》
将持续为您带来会议最新动态
敬请关注！
如发现文内有误请联系我们
来源：EuroPCR 2024
全面工作
传播矩阵
FOLLOW US
苏州工业园区东方华夏心血管健康研究院
电话：0512-68295918
邮箱：info@ccahouse.org
网址：https://www.ccahouse.org
地址：苏州工业园区水坊路36号姑苏会平江馆心脏之家